Australia's CSL faces investor proceeding over disclosure obligations

By Reuters News

- Australian biotech giant CSL CSL.AX said on Thursday it would defend itself against a group proceeding filed in the Supreme Court of Victoria on October 21 alleging breaches related to the firm's forecast financial performance measures.

The proceeding was brought on behalf of investors who acquired certain CSL securities between February 11, 2025, and May 11, 2026, the company said.

Capital Com is an execution-only service provider. The present material must be regarded as marketing communication and should not be interpreted as investment research or investment advice. Any opinion that may be provided on this page does not constitute a recommendation by Capital Com or its agents. We do not make any representations or warranty on the accuracy or completeness of the information that is provided on this page. If you rely on the information on this page, then you do so entirely at your own risk